Login/Register
  • 中文
  • English

News

Formosa Pharmaceuticals to Relaunch Ophthalmic New Drug BICOVI in the US; Targets 50% Market Share

Formosa Pharmaceuticals (台新藥) announced at its February 23rd investor conference that its ophthalmic drug APP13007 (US brand name: BICOVI) is slated for a US relaunch in H1 2026 under its new commercial partner, Harrow.

Read more
Jan 27, 2026
TaiGen Biopharmaceuticals Licenses Flu Candidate Pixavir to Boryung for South Korean Market
Jan 26, 2026
Balancing Industrial Growth with Health Equity: Lessons for Taiwan’s Healthcare Strategy
Jan 26, 2026
AI-Driven Transformation: BioMed Firms Accelerate Drug Discovery and Aesthetics
Jan 26, 2026
NCCN Grants Category 1 Status to PharmaEssentia’s Ropeg for Essential Thrombocythemia (ET)
Jan 26, 2026
StemCyte Receives US Government Grant Extension Through 2027 for Multi-Ethnic Cord Blood Program
Jan 23, 2026
Pet Pharm Biotech to Invest NT$1.5B in New Miaoli Radiopharmaceutical Plant
Jan 23, 2026
Bora Pharmaceuticals Secures US FDA Approval for Restasis® Generic; USL to Lead Launch
Jan 23, 2026
Orient Europharma Partners with Japan’s Dermatology Leader Maruho to Target Hyperhidrosis Market
Jan 22, 2026
UnicoCell Advances into Southeast Asia: Exosomes Secure Cosmetic Notification in the Philippines

Most Watched

Recommended

Unitron Medical Inc._iKypho
National Yang Ming Chiao Tung University
Training Medication Kit
Smart Remote POCT Healthcare Comprehensive Solution
Eternal Materials Co.,Ltd.

Industry Watch

Read more